Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients
NCT01466946 is an observational study sponsored by Memorial Sloan Kettering Cancer Center. As of 21 Nov 2026, it is completed. It studies Lung Cancer. The registry lists an enrollment of 25 participants at 1 site in 1 country. The registry lists a start date of 30 Nov 2011 and a primary completion date of 29 Feb 2016.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01466946 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Memorial Sloan Kettering Cancer Center |
| Enrollment | 25 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Lung Cancer |
| Start | 30 Nov 2011 |
| Primary completion | 29 Feb 2016 |
| Study completion | 29 Feb 2016 |
| Last update posted | 11 Feb 2016 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- William Alago, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Memorial Sloan Kettering Cancer Center
New York
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01466946
Each answer restates registry values shown on this page.
What is NCT01466946?
NCT01466946 is an observational study sponsored by Memorial Sloan Kettering Cancer Center. It studies Lung Cancer.
Who leads NCT01466946?
The registry names William Alago, MD (principal investigator, Memorial Sloan Kettering Cancer Center) as the overall official.
Where does NCT01466946 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT01466946 end?
The registry lists a primary completion date of 29 Feb 2016 and a study completion date of 29 Feb 2016. The sponsor last updated the record on 11 Feb 2016.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.